Cancer du poumon à l’ère du COVID-19: Lung cancer in the COVID-19 era

por Chouaid, C.
Publicado 2020

Update on the treatment of non-small-cell lung cancer: focus on the cost-effectiveness of new agents

por Vergnenègre, A, Borget, I, Chouaid, C
Publicado 2013

Impact of the COVID-19 pandemic on COPD patients: a nationwide mortality study in France

por Poucineau, J, Khlat, M, Lapidus, N, Espagnacq, M, Chouaïd, C, Delory, T, Le Coeur, S
Publicado 2023

Economics of the clinical management of lung cancer in France: an analysis using a Markov model

por Chouaïd, C, Molinier, L, Combescure, C, Daurès, J P, Housset, B, Vergnenègre, A
Publicado 2004

Evolution des facteurs de risque de forme grave de la COVID-19 à travers les trois vagues à partir des données du PMSI

por Rousseau, M., Excoffier, J-B., Salaun-Penquer, N., Ortala, M., Chouaid, C., Jung, C.
Publicado 2022

Analyse des patients hospitalisés pour COVID-19 lors du premier confinement de 2020 à l'aide de méthodes d'explicabilité

por Excoffier, J-B., Salaün-Penquer, N., Ortala, M., Raphaël-Rousseau, M., Chouaid, C., Jung, C.
Publicado 2022

Evolution du profil des patients hospitalisés au cours des trois premières vagues de COVID-19 par des techniques d'apprentissage automatique

por Jung, C., Excoffier, J-B., Raphaël-Rousseau, M., Salaun-Penquer, N., Ortala, M., Chouaid, C.
Publicado 2022

Organisation de la réanimation en situation de pandémie de grippe aviaire

por Guery, B., Guidet, B., Beloucif, S., Floret, D., LeGall, C., Montravers, P., Chouaid, C., Jarreau, P.H., Régnier, B.
Publicado 2008

A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-c...

por LeCaer, H, Barlesi, F, Corre, R, Jullian, H, Bota, S, Falchero, L, Vergnenegre, A, Dujon, C, Delhoume, J Y, Chouaid, C
Publicado 2011

Immune response to pertussis vaccine in COPD patients

por Feredj, E., Wiedemann, A., Krief, C., Maitre, B., Derumeaux, G., Chouaid, C., Le Corvoisier, P., Lacabaratz, C., Gallien, S., Lelièvre, J. D., Boyer, L.
Publicado 2023

Prognostic value of comorbidities in older patients with cancer: the ELCAPA cohort study

por Benderra, M.-A., Serrano, A.G., Paillaud, E., Tapia, C.M., Cudennec, T., Chouaïd, C., Lorisson, E., de la Taille, A., Laurent, M., Brain, E., Bringuier, M., Gligorov, J., Caillet, P., Canoui-Poitrïne, F.
Publicado 2023

Randomised phase II study of ASA404 combined with carboplatin and paclitaxel in previously untreated advanced non-small cell lung cancer

por McKeage, M J, Von Pawel, J, Reck, M, Jameson, M B, Rosenthal, M A, Sullivan, R, Gibbs, D, Mainwaring, P N, Serke, M, Lafitte, J-J, Chouaid, C, Freitag, L, Quoix, E
Publicado 2008

Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study)

por Raynaud, C., Greillier, L., Mazieres, J., Monnet, I., Mastroianni, B., Robinet, G., Fraboulet, G., Dixmier, A., Berard, H., Lamy, R., Letreut, J., Lena, H., Oliviero, G., Botta, S., Vergnenegre, A., Borget, I., Chouaid, C.
Publicado 2015

Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study

por Macro, M., Hulin, C., Vincent, L., Charvet-Rumpler, A., Benboubker, L., Calmettes, C., Stoppa, A.-M., Laribi, K., Clement-Filliatre, L., Zerazhi, H., Honeyman, F., Richez, V., Maloisel, F., Karlin, L., Barrak, J., Chouaid, C., Leleu, X.
Publicado 2023

Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial

por Schuler, M., Yang, J. C.-H., Park, K., Kim, J.-H., Bennouna, J., Chen, Y.-M., Chouaid, C., De Marinis, F., Feng, J.-F., Grossi, F., Kim, D.-W., Liu, X., Lu, S., Strausz, J., Vinnyk, Y., Wiewrodt, R., Zhou, C., Wang, B., Chand, V. K., Planchard, D.
Publicado 2016